Your Health, We Care
ritlecitinib exhibits high selectivity towards Janus kinase 3 (JAK3) and tyrosine kinases in the TEC family.
It blocks the immune intracellular signaling pathway that causes alopecia areata by inhibiting JAK3 dependent receptor-mediated cytokine induced STAT phosphorylation and TEC kinase family member dependent immune receptor signaling.
